Type 1 Diabetes TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.
TrialNet was established in response to the Surgeon General’s Report Healthy People 2000. This report identified diabetes as a national health objective for the Nation. In response to the report, Congress created the Diabetes Research Working Group (DRWG) to develop a plan for diabetes research. One recommendation of the DRWG was to conduct additional research studies (clinical trials) to prevent type 1 diabetes.
What we do at the EPDA:
The EPDA recruits participants based on eligibility and make an appointment for them, bring them in, they complete all necessary paperwork, we draw blood, and send it off to the laboratory where they will test it and see if it contains genetic markers.
If the person happens to be positive, TrialNet will contact them to have them participate in Stage 2 of the study. If the person is negative, then the participant has to follow up every 6 months. We hold monthly clinics that vary depending on phlebotomist’s schedule.
The criteria the participant must meet is:
- Anyone between the ages of 1 and 45 years with a sibling, child or parent with type 1 diabetes.
- Anyone between the ages of 1 and 20 with a sibling, child, parent, cousin, uncle, aunt, niece, nephew, grandparent or half-sibling with type 1 diabetes.
Register here to participate: